GEN-3017

N/A

Report date: 2026/03/19 17:16:29

Base Information

Drug NameGEN-3017

Drug Alias NameDuoBody-CD3xCD30GEN-3017

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CD3Anti-Tumor necrosis factor receptor superfamily member 8

TargetsT cell surface glycoprotein CD3Tumor necrosis factor receptor superfamily member 8

Therapy Area/IndicationsHematologic NeoplasmsLymphoma, Non-HodgkinHodgkin Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesDenmarkAustralia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGenmab A/S

China Registration ClassN/A

Develop Information

Active CompaniesGenmab A/S

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsLymphoma, Non-HodgkinHodgkin Disease

Other Information

ATC CodeN/A